Li W, Liu M, Feng Y, Xu Y-F, Huang Y-F, Che J-P, Wang G-C, Yao X-D, Zheng J-H
Department of Urology, Shanghai Tenth People's Hospital, Tongji University, Shanghai 200072, China.
Department of Nephrology, Nanjing University Affiliated Drum Tower Hospital, Nanjing, Jiangsu 210093, China.
Br J Cancer. 2014 Sep 9;111(6):1188-200. doi: 10.1038/bjc.2014.382. Epub 2014 Jul 10.
Nin one binding protein (NOB1) was identified as a potential oncogene in human glioma and miR-646 plays an important role in human growth and development. However, the underlying molecular mechanisms of NOB1 in tumorigenicity and its correlation with miR-646 in renal cell carcinoma (RCC) have not been investigated.
We performed bioinformatic analysis to explore miRNA targeting NOB1. The expression of NOB1 and miR-646 from 100 cases of clear cell RCC (ccRCC) and 30 cases of adjacent non-tumour tissues were detected by quantitative real-time PCR. The expression of miR-646 was correlated with NOB1 expression, tumour features and patient metastasis-free survival. The effect of overexpression of mir-646 on renal cancer cell proliferation was detected by colony formation in soft agar. Using a xenograft tumour model, we observed the in vivo tumorigenesis effect of miR-646 and NOB1.
miR-646 negatively regulated NOB1 and inhibited the proliferation and migration of renal cancer cells. There was a significant upregulation of NOB1 in ccRCC and it was further increased in metastatic cases, while miR-646 was downregulated in tumour tissues and further decreased in metastatic ccRCC. Additionally, expression of miR-646 was inversely correlated with the expression of NOB1. The downregulation of miR-646 also indicated a higher probability of developing metastasis. Most importantly, miR-646 expression was an independent predictor of ccRCC metastasis by the univariate analysis and binary logistic regression model (both P<0.05). Colony formation in soft agar and xenograft tumour model suggested that miR-646 and NOB1 are required for tumorigenesis in vitro and in vivo. Furthermore, suppression of NOB1 increased the phosphorylation of several proteins in MAPK pathway.
Downregulated miR-646 in ccRCC was associated with tumour metastasis through MAPK pathway by targeting NOB1. miR-646 and NOB1 may play an important role in the development of ccRCC.
Nin 1结合蛋白(NOB1)被鉴定为人类胶质瘤中的潜在致癌基因,且miR - 646在人类生长发育中起重要作用。然而,NOB1在肾细胞癌(RCC)致瘤性中的潜在分子机制及其与miR - 646的相关性尚未得到研究。
我们进行了生物信息学分析以探索靶向NOB1的微小RNA(miRNA)。通过定量实时聚合酶链反应(qRT - PCR)检测了100例透明细胞肾细胞癌(ccRCC)和30例癌旁非肿瘤组织中NOB1和miR - 646的表达。将miR - 646的表达与NOB1表达、肿瘤特征及患者无转移生存期相关联。通过软琼脂集落形成检测过表达miR - 646对肾癌细胞增殖的影响。使用异种移植肿瘤模型,我们观察了miR - 646和NOB1的体内致瘤作用。
miR - 646负向调节NOB1并抑制肾癌细胞的增殖和迁移。在ccRCC中NOB1显著上调,且在转移病例中进一步升高,而miR - 646在肿瘤组织中下调,在转移性ccRCC中进一步降低。此外,miR - 646的表达与NOB1的表达呈负相关。miR - 646的下调也表明发生转移的可能性更高。最重要的是,通过单因素分析和二元逻辑回归模型,miR - 646表达是ccRCC转移的独立预测因子(两者P<0.05)。软琼脂集落形成和异种移植肿瘤模型表明,miR - 646和NOB1在体外和体内致瘤过程中是必需的。此外,抑制NOB1增加了丝裂原活化蛋白激酶(MAPK)途径中几种蛋白的磷酸化。
ccRCC中miR - 646下调通过靶向NOB1经MAPK途径与肿瘤转移相关。miR - 646和NOB1可能在ccRCC的发生发展中起重要作用。